Literature DB >> 18279222

Intravenous rifampicin for persistent staphylococcal bacteremia in premature infants.

Amuchou Singh Soraisham1, Mohammed Yasir Al-Hindi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18279222     DOI： 10.1111/j.1442-200X.2007.02519.x

Source DB:  PubMed          Journal:  Pediatr Int        ISSN： 1328-8067            Impact factor:   1.524


× No keyword cloud information.
  3 in total

1.  Combination of vancomycin and rifampicin for the treatment of persistent coagulase-negative staphylococcal bacteremia in preterm neonates.

Authors:  Luciana Rodriguez-Guerineau; María Dolors Salvia-Roigés; Marisol León-Lozano; José Manuel Rodríguez-Miguélez; Josep Figueras-Aloy
Journal:  Eur J Pediatr       Date:  2013-01-18       Impact factor: 3.183

2.  Use of rifampin in persistent coagulase negative staphylococcal bacteremia in neonates.

Authors:  N Margreth van der Lugt; Sylke J Steggerda; Frans J Walther
Journal:  BMC Pediatr       Date:  2010-11-19       Impact factor: 2.125

3.  Rifampin use and safety in hospitalized infants.

Authors:  Christopher J Arnold; Jessica Ericson; Jordan Kohman; Kaitlyn L Corey; Morgan Oh; Janet Onabanjo; Christoph P Hornik; Reese H Clark; Daniel K Benjamin; P Brian Smith; Vivian H Chu
Journal:  Am J Perinatol       Date:  2015-01-16       Impact factor: 3.079
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.